Delivery Order SPE2DB22D3501-SPE2DB23FXF77
Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $7.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,348.57 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to provide 4561598113 EPTIFIBATIDE 75 MG/100 ML VIAL 100ML. The place of performance will be in Conshohocken, Pennsylvania, with work scheduled to be completed between July 25-26, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger indefinite delivery/indefinite quantity...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Eptifibatide 75 mg/100 mL bags totaling $2,048.65 with a completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement executed under...
- The Defense Logistics Agency awarded a $7,439.67 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561805992 EPTIFIBATIDE 75 MG/100 ML VIAL 100ML. The place of performance is Conshohocken, Pennsylvania. The contract period of performance is from August 14, 2023 through August 15, 2023. The Defense Logistics Agency supports military readiness by procuring, managing and distributing medical supplies and pharmaceuticals to military treatment facilities worldwide. As the...
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,989.00 for the provision of 4564552749 - EPTIFIBATIDE 75 MG/100 ML VIAL 100ML. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the world's largest pharmaceutical distribution companies. This Delivery Order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- This delivery order awards AmerisourceBergen Drug Corp a $1,659.24 firm fixed-price contract for the supply of Eptifibatide 75 mg/100 mL vials to support federal medical procurement needs. The award, issued by the Defense Logistics Agency on December 16, 2025, with an ultimate completion date of December 17, 2025, represents a non-set-aside competitive award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eptifibatide is a...
- This federal contract award is for the delivery of EPTIFIBATIDE 20 MG/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,183.20 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,753.38 Firm Fixed Price Delivery Order is for the supply of Eptifibatide 75 mg/100 ml vials, which are critical pharmaceutical products used in medical treatments. The order has an ultimate completion date of October 15, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts and indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation operating through its Corporate Office division, has received a $1,223.92 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical program. The order is for 100 milliliter vials of Eptifibatide 75 milligrams/100 milliliters to be delivered by December 14, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,676.32 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of September 12, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,237.63 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Activase 100 mg vials, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXF77Delivery Order
The Defense Logistics Agency awarded a $7,482.51 delivery order to Amerisourcebergen Drug Corporation for 4562215093 EPTIFIBATIDE 75 MG/100 ML VIAL 100ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide pharmaceutical products to DLA facilities located in Conshohocken, Pennsylvania. Performance will take place from September 18-19, 2023. No subcontractors or set aside designations were identified. This order supports DLA's mission to provide medical supplies and equipment to military treatment facilities worldwide.
Generated 12/18/23, 11:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/18/23 |